Last reviewed · How we verify
NCT06044584: pAIn-sense
Unveiling Physiological and Psychosocial Pain Components with an Artificial Intelligence Based Telemonitoring Tool
trial testing No intervention in Nociceptive Pain in 150 participants. Currently enrolling.
15 December 2028
Quick facts
| Lead sponsor | ETH Zurich |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 29 September 2023 |
| Primary completion | 15 December 2028 |
| Estimated completion | 31 December 2028 |
| Sites | 4 locations across Italy, Switzerland |
Drugs / interventions tested
- No intervention
Conditions studied
- Nociceptive Pain — all drugs for Nociceptive Pain →
- Neuropathic Pain — all drugs for Neuropathic Pain →
Sponsor
ETH Zurich — full company profile →
Who can join
Adults 18 to 80, any sex, with Nociceptive Pain or Neuropathic Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The pAIn-sense study aims to revolutionize the monitoring and treatment of chronic pain, a major health concern that significantly impacts psychological well-being and quality of life. Traditional approaches to pain management face challenges like unspecific drug use and high healthcare costs, and they often leave patients dissatisfied. PAIn-sense aims at comprehensively understanding pain from both physical and emotional perspectives. To accomplish this, the study will employ advanced Artificial Intelligence (AI) techniques and wearable sensing technology. The study aims to monitor patients continuously, during both day and night activities, to gather a multidimensional set of data on their physiological, psychosocial, and pain conditions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06044584
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of No intervention
Trials testing the same drug.
- NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
- NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
- NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
- NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
- NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
Other recruiting trials for Nociceptive Pain
Currently open trials in the same condition.
- NCT07321080 — Central Sensitisation in Nociceptive and Neuropathic Pain · active not recruiting
- NCT07084935 — Comparison of the Surgical Pleth Index and the Nociception Level Index in the Pediatric Population · recruiting
- NCT06443281 — Pain Phenotyping in Patients With Neuropathic Pain After Spinal Cord Injury · recruiting
- NCT06291363 — Impact of Administration of Esmolol on Nociception Level-guided Control of Nociception. · Phase 4 · recruiting
Other ETH Zurich trials
Trials by the same sponsor.
- NCT07435766 — Iron Absorption From IFA and MMS Supplements in Kenyan Women During the Second Trimester of Pregnancy · NA · recruiting
- NCT07315295 — Maximizing the Benefits of Iron in Ready-to-Use Therapeutic Foods for Malnourished Children in Kenya · NA · recruiting
- NCT07119411 — ICU Background Early Awareness for Critical deterioratiON · not yet recruiting
- NCT06856291 — Response to Semaglutide in Non-diabetic Obese Patients With Varying Degrees of Insulin Resistance · recruiting
- NCT06814327 — Assessment of Organ Failure Risk Predictions in ICU · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06044584 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by ETH Zurich
- Last refreshed: 20 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06044584.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing